ARBS — Arterra Bioscience SpA Balance Sheet
0.000.00%
Last trade - 00:00- €14.95m
- €11.52m
- €3.30m
- 88
- 55
- 87
- 93
Annual balance sheet for Arterra Bioscience SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.67 | 4.54 | 4.81 | 5.99 | 3.69 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.95 | 2.69 | 3.19 | 2.66 | 2.84 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 7.12 | 7.91 | 8.53 | 9.85 | 7.93 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.28 | 1.4 | 1.66 | 1.54 | 1.23 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 9.55 | 10.3 | 11.6 | 12.6 | 12.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.77 | 1.52 | 1.59 | 1.47 | 1.14 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.44 | 2.14 | 2.11 | 2.1 | 1.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 7.11 | 8.18 | 9.47 | 10.5 | 10.8 |
| Total Liabilities & Shareholders' Equity | 9.55 | 10.3 | 11.6 | 12.6 | 12.6 |
| Total Common Shares Outstanding |